“Alterations In The Human Plasma Lipidome In Response To Tularemia Vaccination.”. Vaccines (Basel) 8 (3). Vaccines (Basel). doi:10.3390/vaccines8030414. https://pubmed.ncbi.nlm.nih.gov/32722213/.
. 2020. “Baseline Levels Of Influenza-Specific B Cells And T Cell Responses Modulate Human Immune Responses To Swine Variant Influenza A/h3N2 Vaccine.”. Vaccines (Basel) 8 (1). Vaccines (Basel). doi:10.3390/vaccines8010126.
. 2020. “Clinical, Virologic, And Immunologic Characteristics Of Zika Virus Infection In A Cohort Of Us Patients: Prolonged Rna Detection In Whole Blood.”. Open Forum Infect Dis 6 (1). Open Forum Infect Dis: ofy352. doi:10.1093/ofid/ofy352.
. 2019. “Comparison Of Lyophilized Versus Liquid Modified Vaccinia Ankara (Mva) Formulations And Subcutaneous Versus Intradermal Routes Of Administration In Healthy Vaccinia-Naïve Subjects.”. Vaccine 33 (39). Vaccine: 5225-34. doi:10.1016/j.vaccine.2015.06.075.
. 2015. “Duration Of Cellular And Humoral Responses After Quadrivalent Human Papillomavirus Vaccination In Healthy Female Adults With Or Without Prior Type 16 And/or 18 Exposure.”. Vaccines (Basel) 8 (3). Vaccines (Basel). doi:10.3390/vaccines8030348.
. 2020. “Immunogenicity And Safety Of Four Different Dosing Regimens Of Anthrax Vaccine Adsorbed For Post-Exposure Prophylaxis For Anthrax In Adults.”. Vaccine 32 (47). Vaccine: 6284-93. doi:10.1016/j.vaccine.2014.08.076.
. 2014. “Immunogenicity And Safety Of Varying Dosages Of A Monovalent 2009 H1N1 Influenza Vaccine Given With And Without As03 Adjuvant System In Healthy Adults And Older Persons.”. J Infect Dis 206 (6). J Infect Dis: 811-20. doi:10.1093/infdis/jis427.
. 2012. “Immunogenicity Of Avian Influenza A/anhui/01/2005(H5N1) Vaccine With Mf59 Adjuvant: A Randomized Clinical Trial.”. Jama 312 (14). Jama: 1420-8. doi:10.1001/jama.2014.12609.
. 2014. “Plasmablast, Memory B Cell, Cd4+ T Cell, And Circulating Follicular Helper T Cell Responses To A Non-Replicating Modified Vaccinia Ankara Vaccine.”. Vaccines (Basel) 8 (1). Vaccines (Basel). doi:10.3390/vaccines8010069.
. 2020. “Proteomic Analysis Of Human Immune Responses To Live-Attenuated Tularemia Vaccine.”. Vaccines (Basel) 8 (3). Vaccines (Basel). doi:10.3390/vaccines8030413. https://pubmed.ncbi.nlm.nih.gov/32722207/.
. 2020. “Randomized Clinical Trial Of A Single Versus A Double Dose Of 13-Valent Pneumococcal Conjugate Vaccine In Adults 55 Through 74 Years Of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine.”. Vaccine 36 (5). Vaccine: 606-614. doi:10.1016/j.vaccine.2017.12.061.
. 2018. “Safety And Immunogenicity Of A Modified Vaccinia Ankara Vaccine Using Three Immunization Schedules And Two Modes Of Delivery: A Randomized Clinical Non-Inferiority Trial.”. Vaccine 35 (13). Vaccine: 1675-1682. doi:10.1016/j.vaccine.2017.02.032.
. 2017. “Serological Responses To An Avian Influenza A/h7N9 Vaccine Mixed At The Point-Of-Use With Mf59 Adjuvant: A Randomized Clinical Trial.”. Jama 312 (14). Jama: 1409-19. doi:10.1001/jama.2014.12854.
. 2014. “Systems Vaccinology For A Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral And Cellular Immune Responses.”. Vaccines (Basel) 8 (1). Vaccines (Basel). doi:10.3390/vaccines8010004.
. 2019. “Transcriptomic And Metabolic Responses To A Live-Attenuated Vaccine.”. Vaccines (Basel) 8 (3). Vaccines (Basel). doi:10.3390/vaccines8030412. https://pubmed.ncbi.nlm.nih.gov/32722194/.
. 2020. “Tularemia Vaccine: Safety, Reactogenicity, "take" Skin Reactions, And Antibody Responses Following Vaccination With A New Lot Of The Francisella Tularensis Live Vaccine Strain - A Phase 2 Randomized Clinical Trial.”. Vaccine 35 (36). Vaccine: 4730-4737. doi:10.1016/j.vaccine.2017.07.024.
. 2017.